“With the United States funding 70 percent of the world’s research and development of biomedical answers to HIV prevention, progress that has yielded the potential for immediate advances against the global epidemic is in danger of stalling, with lasting consequences, according to a report [.pdf] released at the International AIDS Society [IAS] conference in Kuala Lumpur this week,” the Center for Global Health Policy’s “Science Speaks” blog reports. “‘From Research to Reality, Investing in HIV Prevention Research in a Challenging Landscape’ examines investments, outcomes and next steps in HIV vaccine and microbicide research, antiretroviral treatment as prevention, pre-exposure prophylactic use of antiretroviral drugs, medical circumcision, as well as other biomedical prevention approaches,” the blog notes, and details some of the report’s findings. “The report, which includes graphics illustrating not only current funding sources, but research involvement through trial participation, concludes the potential of more productive partnerships exists,” the blog states (Barton, 7/2).